Linagliptin 5mg + Dapagliflozin 10mg is a combination oral medication used for the management of type 2 diabetes mellitus. Linagliptin is a DPP-4 inhibitor that works by enhancing the levels of incretin hormones, which help regulate blood glucose by increasing insulin secretion and decreasing glucagon release. Dapagliflozin is an SGLT2 inhibitor that helps lower blood sugar by promoting glucose excretion through the urine. This combination provides dual action to improve glycemic control, reduce postprandial glucose spikes, and support overall metabolic health. It is suitable for adults who require additional glycemic management alongside diet and exercise.
